LabCompass

Sagar Sardesai

Medicine · The Ohio State University

Mid career · publishing since 2009

Publications

94

Citations

1,347

Est. group size

~24

Recurring co-author estimate

Active years

17

Publishing since 2009

Research summary
AI-generated

Sagar Sardesai's research focuses on clinical trials and treatment strategies for breast cancer, particularly hormone receptor-positive and triple-negative subtypes. Work includes studies of new drugs (such as CDK7 inhibitors, PIK3CA inhibitors, and antibody-drug conjugates) and the use of blood-based tumor DNA testing to monitor cancer during treatment. Much of the research involves multi-site clinical trials reported at major oncology conferences and journals.

Breast cancer clinical trialsTargeted cancer therapies (CDK7, PIK3CA inhibitors)Circulating tumor DNA (ctDNA) monitoringHER2 and hormone receptor-positive breast cancerTriple-negative breast cancer treatment

Publication output has grown substantially since 2018, rising from just 1-2 papers per year to a sustained pace of roughly 9-16 papers annually over the past five years, with continued high activity through 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 9.6/year recently
2017: 2 publications172018: 1 publication182019: 11 publications192020: 10 publications202021: 16 publications16212022: 11 publications222023: 12 publications232024: 9 publications242025: 16 publications162526
Recent publications
Publishes in
  • Journal of Clinical Oncology×16
  • Cancer Research×14
  • Clinical Cancer Research×5
  • Annals of Oncology×4
  • Nature Communications×3
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile